We are live on
!
Find out more
SA
Shilanski & Associates Portfolio holdings
AUM
$376M
1-Year Est. Return
19.08%
This Fund
S&P 500
This Quarter
Est. Return
+0.67%
1 Year Est. Return
+19.08%
3 Year Est. Return
+84.25%
5 Year Est. Return
+122.72%
10 Year Est. Return
–
AUM
$238M
AUM Growth
+$3.56M
(+1.5%)
Cap. Flow
+$5.07M
Cap. Flow
% of AUM
2.13%
Top 10 Holdings %
Top 10 Hldgs %
35.48%
Holding
140
New
25
Increased
59
Reduced
34
Closed
17
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.71M |
| 2 |
McKesson
MCK
|
+$1.39M |
| 3 |
Ford
F
|
+$1.35M |
| 4 |
National Fuel Gas
NFG
|
+$1.31M |
| 5 |
Brown & Brown
BRO
|
+$1.25M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zebra Technologies
ZBRA
|
+$2.13M |
| 2 |
Trex
TREX
|
+$1.72M |
| 3 |
Target
TGT
|
+$1.65M |
| 4 |
Deckers Outdoor
DECK
|
+$1.44M |
| 5 |
Carrier Global
CARR
|
+$1.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.89% |
| 2 | Consumer Staples | 8.64% |
| 3 | Financials | 7.14% |
| 4 | Energy | 5.02% |
| 5 | Healthcare | 4.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
126
Bio-Rad Laboratories Class A
BIO
$8.91B
| – | – |
-1,225
| Closed | -$926K |
|
127
BioNTech
BNTX
$23.1B
| – | – |
-1,136
| Closed | -$293K |
|
|
128
Carrier Global
CARR
$54.1B
| – | – |
-25,742
| Closed | -$1.4M |
|
129
CRH
CRH
$65.8B
| – | – |
-4,210
| Closed | -$222K |
|
130
Charles River Laboratories
CRL
$11.3B
| – | – |
-3,284
| Closed | -$1.24M |
|
|
131
Deckers Outdoor
DECK
$13.6B
| – | – |
-23,514
| Closed | -$1.44M |
|
132
Galicia Financial Group
GGAL
$7.86B
| – | – |
-17,422
| Closed | -$165K |
|
133
H&R Block
HRB
$5.84B
| – | – |
-50,552
| Closed | -$1.2M |
|
134
iShares Russell 2000 ETF
IWM
$83B
| – | – |
-974
| Closed | -$217K |
|
135
iShares Russell 2000 Growth ETF
IWO
$15B
| – | – |
-758
| Closed | -$222K |
|
136
KT
KT
$8.79B
| – | – |
-15,309
| Closed | -$192K |
|
137
Invesco Dorsey Wright Momentum ETF
PDP
$1.52B
| – | – |
-2,232
| Closed | -$211K |
|
138
RH
RH
$3.56B
| – | – |
-2,204
| Closed | -$1.18M |
|
|
139
Trex
TREX
$4.89B
| – | – |
-12,732
| Closed | -$1.72M |
|
|
140
Zebra Technologies
ZBRA
$17.6B
| – | – |
-3,580
| Closed | -$2.13M |
|
Similar funds
NELSF
MFGP
BCCM
PA
BWA
PAWA
CPA
AACP
Shilanski & Associates's Q1 2022 Portfolio in Review
As of Q1 2022, Shilanski & Associates held 140 positions worth $238M, up 1.5% from $235M the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Shilanski & Associates's Q1 2022 filing shows 25 new, 59 increased, 34 reduced and 17 closed positions. Its largest new stake was McKesson: 5,107 shares worth $1.56M. The largest sale was Zebra Technologies, an estimated $2.13M.
By sector, the portfolio is most concentrated in Technology at 9.9% of assets, down from 11% a quarter earlier, followed by Consumer Staples and Financials.
- Shilanski & Associates's largest Q1 2022 buy was McKesson: 5,107 shares worth $1.56M.
- Shilanski & Associates added most to State Street SPDR S&P 500 ETF Trust in Q1 2022, an estimated $1.71M increase.
- Shilanski & Associates's biggest Q1 2022 reduction was Target, cutting an estimated $1.65M.
- Shilanski & Associates fully exited Zebra Technologies in Q1 2022, selling an estimated $2.13M.
- Shilanski & Associates's ten largest holdings make up 35% of its $238M portfolio in Q1 2022.
- Shilanski & Associates opened 25 new positions and closed 17 in Q1 2022.
- Shilanski & Associates's portfolio value rose 1.5% quarter-over-quarter to $238M.
Based on Shilanski & Associates's 13F filing for Q1 2022, filed 20 Apr 2022.